These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 33150525

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19.
    Laghlam D, Rahoual G, Malvy J, Estagnasié P, Brusset A, Squara P.
    Front Med (Lausanne); 2021; 8():655763. PubMed ID: 34277653
    [Abstract] [Full Text] [Related]

  • 3. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome.
    Jolliet P, Bulpa P, Ritz M, Ricou B, Lopez J, Chevrolet JC.
    Crit Care Med; 1997 May; 25(5):786-94. PubMed ID: 9187597
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of almitrine as a rescue therapy for refractory hypoxemia in COVID and non-COVID acute respiratory distress syndrome. A retrospective monocenter study.
    Blot PL, DE Roquetaillade C, Deniau B, Gaugain S, Kindermans M, Julian N, LE Dorze M, Mebazaa A, Chousterman BG, Barthélémy R.
    Minerva Anestesiol; 2023 Mar; 89(3):157-165. PubMed ID: 36287391
    [Abstract] [Full Text] [Related]

  • 5. Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. The NO Almitrine Study Group.
    Gallart L, Lu Q, Puybasset L, Umamaheswara Rao GS, Coriat P, Rouby JJ.
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1770-7. PubMed ID: 9847266
    [Abstract] [Full Text] [Related]

  • 6. Inhaled nitric oxide, almitrine infusion, or their coadministration as a treatment of severe hypoxemic focal lung lesions.
    Paven D, Muret J, Beloucif S, Gatecel C, Kermarrec N, Guinard N, Mateo J.
    Anesthesiology; 1998 Nov; 89(5):1157-65. PubMed ID: 9822004
    [Abstract] [Full Text] [Related]

  • 7. Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide-responding patients with acute respiratory distress syndrome.
    Lu Q, Mourgeon E, Law-Koune JD, Roche S, Vézinet C, Abdennour L, Vicaut E, Puybasset L, Diaby M, Coriat P.
    Anesthesiology; 1995 Nov; 83(5):929-43. PubMed ID: 7486178
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
    Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N, Al Zumai O, Alrubayan F, Asiri A, Alkahtani N, Alolayan A, Alsohimi S, Melibari N, Almagthali A, Aljahdali S, Alenazi AA, Alsaeedi AS, Al Ghamdi G, Al Faris O, Alqahtani J, Al Qahtani J, Alshammari KA, Alshammari KI, Aljuhani O.
    Crit Care; 2022 Oct 03; 26(1):304. PubMed ID: 36192801
    [Abstract] [Full Text] [Related]

  • 9. High or low doses of almitrine bismesylate in ARDS patients responding to inhaled NO and receiving norepinephrine?
    Roch A, Papazian L, Bregeon F, Gainnier M, Michelet P, Thirion X, Saux P, Thomas P, Jammes Y, Auffray JP.
    Intensive Care Med; 2001 Nov 03; 27(11):1737-43. PubMed ID: 11810116
    [Abstract] [Full Text] [Related]

  • 10. Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
    Caplan M, Goutay J, Bignon A, Jaillette E, Favory R, Mathieu D, Parmentier-Decrucq E, Poissy J, Duburcq T, Lille Intensive Care COVID-19 Group.
    Crit Care Med; 2021 Feb 01; 49(2):e191-e198. PubMed ID: 33093279
    [Abstract] [Full Text] [Related]

  • 11. Prone positioning and inhaled nitric oxide: synergistic therapies for acute respiratory distress syndrome.
    Johannigman JA, Davis K, Miller SL, Campbell RS, Luchette FA, Frame SB, Branson RD.
    J Trauma; 2001 Apr 01; 50(4):589-95; discussion 595-6. PubMed ID: 11318005
    [Abstract] [Full Text] [Related]

  • 12. Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome.
    Albert M, Corsilli D, Williamson DR, Brosseau M, Bellemare P, Delisle S, Nguyen AQ, Varin F.
    World J Crit Care Med; 2017 Feb 04; 6(1):74-78. PubMed ID: 28224110
    [Abstract] [Full Text] [Related]

  • 13. Acute oxygenation response to inhaled nitric oxide when combined with high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome.
    Mehta S, MacDonald R, Hallett DC, Lapinsky SE, Aubin M, Stewart TE.
    Crit Care Med; 2003 Feb 04; 31(2):383-9. PubMed ID: 12576940
    [Abstract] [Full Text] [Related]

  • 14. Combined nitric oxide inhalation, prone positioning and almitrine infusion improve oxygenation in severe ARDS.
    Gillart T, Bazin JE, Cosserant B, Guelon D, Aigouy L, Mansoor O, Schoeffler P.
    Can J Anaesth; 1998 May 04; 45(5 Pt 1):402-9. PubMed ID: 9598253
    [Abstract] [Full Text] [Related]

  • 15. Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome.
    Abman SH, Fox NR, Malik MI, Kelkar SS, Corman SL, Rege S, Bhaloo J, Shah R, Shei RJ, Saporito D, Shamseddine N, DeBoer E, Wan GJ.
    Drugs Context; 2022 May 04; 11():. PubMed ID: 35462641
    [Abstract] [Full Text] [Related]

  • 16. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome.
    Wysocki M, Delclaux C, Roupie E, Langeron O, Liu N, Herman B, Lemaire F, Brochard L.
    Intensive Care Med; 1994 May 04; 20(4):254-9. PubMed ID: 8046118
    [Abstract] [Full Text] [Related]

  • 17. Inhaled nitric oxide as rescue therapy in severe ARDS cases due to COVID-19 pneumonia: a single center experience.
    Bicakcioglu M, Kalkan S, Duzenci D, Yalcinsoy M, Dogan Z, Ozer AB.
    Eur Rev Med Pharmacol Sci; 2023 Jul 04; 27(13):6422-6428. PubMed ID: 37458665
    [Abstract] [Full Text] [Related]

  • 18. Inhaled Nitric Oxide in Acute Severe Pulmonary Hypertension and Severe Acute Respiratory Distress Syndrome Secondary to COVID-19 Pneumonia: A Case Report.
    Vives M, Gascó I, Pla G, Maciel JL, Ricart Hernandez A, Regí Roman K, Parramon F.
    Am J Case Rep; 2022 Oct 25; 23():e937147. PubMed ID: 36281210
    [Abstract] [Full Text] [Related]

  • 19. Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes.
    Mekontso Dessap A, Papazian L, Schaller M, Nseir S, Megarbane B, Haudebourg L, Timsit JF, Teboul JL, Kuteifan K, Gainnier M, Slama M, Houeto P, Lecourt L, Mercat A, Vieillard-Baron A.
    Ann Intensive Care; 2023 Jun 27; 13(1):57. PubMed ID: 37368036
    [Abstract] [Full Text] [Related]

  • 20. Inhaled nitric oxide and vasoconstrictors in acute respiratory distress syndrome.
    Papazian L, Roch A, Bregeon F, Thirion X, Gaillat F, Saux P, Fulachier V, Jammes Y, Auffray JP.
    Am J Respir Crit Care Med; 1999 Aug 27; 160(2):473-9. PubMed ID: 10430716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.